Plan Your Visit
Surgery Resources
INTAKE HISTORY FORM
Please fill this form to the best of your ability. Download
DEMOGRAPHICS FORM Download
FINANCIAL POLICY Download
Additional forms and documents that need to be reviewed
Advance-Beneficiary-Notice (pdf) Download
Benefits-Assignment (pdf) Download
Medical-Record-Release-Inbound (pdf) Download
Request-to-Amend-Medical-Record (pdf) Download
Surprise-Billing-Acknowledgment-Form (pdf) Download
Telehealth-Consent-Form (pdf) Download
Self Pay Price-List (pdf) Download
Financial Policy (pdf) Download
Resources
Downloads
Caregiving for a Loved One With Lung Cancer (pdf)
Download
Lung Cancer Screening Brochure (pdf)
Download
Breathe Easy Guide (pdf) Download
Immunotherapy for Lung Cancer (pdf) Download
Living With Lung Cancer (pdf) Download
Intake History Form (pdf) Download
Faqs About Health Plan (pdf) Download
Surprise-Billing-Acknowledgment-Form (pdf) Download
Surprise Billing Protection (pdf) Download
TNM Lung Staging Guide
Lung Cancer Staging (TNM – 9th Edition)
A plain-language guide to what “stage” means and how it’s determined.
What does “TNM” mean?
Doctors describe lung cancer using three parts: T (the size/extent of the main Tumor), N (whether nearby lymph Nodes contain cancer), and M (whether the cancer has Metastasized, meaning spread to other organs). These are combined to assign an overall stage (I–IV).:contentReference[oaicite:0]{index=0}
T: Primary Tumor
- T1 – A small tumor (≤3 cm) limited to the lung. Subtypes T1a (≤1 cm), T1b (>1–2 cm), T1c (>2–3 cm).:contentReference[oaicite:1]{index=1}
- T2 – 3–5 cm or involves the main bronchus (not the carina), visceral pleura, causes atelectasis/pneumonitis; T2a (>3–4 cm) or T2b (>4–5 cm).:contentReference[oaicite:2]{index=2}
- T3 – 5–7 cm or invades chest wall/parietal pleura, pericardium, phrenic nerve, azygos vein, or has separate nodule(s) in the same lobe.:contentReference[oaicite:3]{index=3}
- T4 – >7 cm or invades mediastinum, diaphragm, trachea/carina, great vessels, vertebral body, esophagus, recurrent laryngeal or vagus nerves, or has separate nodule(s) in a different lobe on the same side.:contentReference[oaicite:4]{index=4}
Your imaging and, when needed, bronchoscopy or surgery help determine T.
N: Lymph Nodes
- N0 – No lymph nodes involved.:contentReference[oaicite:5]{index=5}
- N1 – Nodes inside the lung or near the main airway (hilar/intrapulmonary).:contentReference[oaicite:6]{index=6}
- N2a/N2b – Single or multiple stations in the central chest (ipsilateral mediastinal/subcarinal).:contentReference[oaicite:7]{index=7}
- N3 – Nodes on the other side of the chest or above the collarbone (contra- or supraclavicular).:contentReference[oaicite:8]{index=8}
M: Metastasis
- M0 – No spread outside the chest.:contentReference[oaicite:9]{index=9}
- M1a – Cancer in the other lung or cancerous fluid/nodules in the pleura/pericardium.:contentReference[oaicite:10]{index=10}
- M1b – A single spot in one organ outside the chest (e.g., liver, brain, bone) or a single non-regional lymph node.:contentReference[oaicite:11]{index=11}
- M1c1 – Multiple metastases within a single organ system (e.g., multiple liver lesions).:contentReference[oaicite:12]{index=12}
- M1c2 – Metastases in multiple organ systems (e.g., liver and bone).:contentReference[oaicite:13]{index=13}
Stage Groups (I–IV)
After T, N, and M are known, they’re combined to assign an overall stage:
- Stage I – Small and limited to the lung (no nodes, no spread).:contentReference[oaicite:14]{index=14}
- Stage II – Larger and/or some nearby lymph nodes.:contentReference[oaicite:15]{index=15}
- Stage III – More advanced lymph nodes or invasion into nearby structures (still potentially treatable with curative intent in select cases).:contentReference[oaicite:16]{index=16}
- Stage IV – Spread outside the chest (metastatic).:contentReference[oaicite:17]{index=17}
Your care team will review imaging, biopsy results, and sometimes surgical findings to finalize staging.
Why Staging Matters
- Treatment planning: guides surgery, radiation, chemotherapy, targeted therapy, and immunotherapy choices.
- Prognosis: helps estimate likely outcomes and response to therapy.
- Consistency: gives clinicians a shared language worldwide.:contentReference[oaicite:18]{index=18}
Questions to Ask Your Team
About This Page
Content adapted to patient-friendly language from the International Association for the Study of Lung Cancer (IASLC) 9th Edition TNM updates and nodal maps.:contentReference[oaicite:19]{index=19} This page does not replace medical advice specific to your case.